US 7258863
Heterologous protection induced by immunization with invaplex vaccine
granted A61KA61K2039/55572A61K39/0283
Quick answer
US patent 7258863 (Heterologous protection induced by immunization with invaplex vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/55572, A61K39/0283, A61P, A61P31/04